Can Cui > Goodwin > San Francisco, United States > Lawyer Profile

Can Cui

+14157336081 CCui@goodwinlaw.com

Position

Partner

Career

Dr. Can Cui is a partner in Goodwin’s Life Sciences group and a co-leader of the firm’s Life Sciences practice in Asia. His practice focuses on technology transactions and investment in the life sciences industry, especially those transactions related to China, including cross-border technology licensing and acquisition, collaboration and strategic partnership, joint venture (JV), and other forms of investment.

Dr. Cui has extensive experience representing both licensors and licensees in US-China life sciences licensing transactions. In private equity and venture capital transactions, he regularly represents institutional and individual investors, established life sciences companies and startups in intellectual property (IP) due diligence and the negotiation and drafting of related investment documentation. He also advises clients on IP aspects of mergers and acquisitions.

Dr. Cui has deep knowledge of China’s increasingly complex regulatory landscape, including not only the IP laws, but also regulations governing cross-border transactions, such as technology import and export regulations and regulations of human genetic resources. He also has rich experiences in corporate matters, patent prosecution and IP dispute resolution, which, together with his scientific background, make him a go-to person for advice in various legal matters life sciences companies may have.

In addition to his legal services to the life sciences industry, Dr. Cui is also an active participant in a wide variety of pro bono matters. He has been a recipient of the California Lawyers Association’s Wiley W. Manuel Certificate for Pro Bono Legal Services in recent years.

Education

JD, New York University School of Law (magna cum laude; Order of the Coif) 2012 / PhD, Biological Chemistry & Molecular Pharmacology, Harvard University 2007 / BSc, Biotechnology, Peking University (summa cum laude) 2000